MyMD Pharmaceuticals Price on July 26, 2024
MYMDDelisted Stock | USD 1.82 0.02 1.09% |
If you're considering investing in MyMD Stock, it is important to understand the factors that can impact its price. As of today, the current price of MyMD Pharmaceuticals stands at 1.82, as last reported on the 26th of December, with the highest price reaching 1.89 and the lowest price hitting 1.82 during the day. We have found twenty-three technical indicators for MyMD Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify MyMD Pharmaceuticals' risk adjusted performance of (0.11), and Mean Deviation of 3.6 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
MyMD Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
MyMD |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
MYMD |
Based on monthly moving average MyMD Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MyMD Pharmaceuticals by adding MyMD Pharmaceuticals to a well-diversified portfolio.
Related Headline
NovaBay Pharmaceuticals Headline on 26th of July 2024
NovaBay Pharmaceuticals announces pricing of 3.5M underwritt... by seekingalpha.com
NovaBay Pharmaceuticals announced the pricing of its underwritten public offering of 3.2M shares of common stock and warrants at a combined price of 1.10...
MyMD Pharmaceuticals Valuation on July 26, 2024
It is possible to determine the worth of MyMD Pharmaceuticals on a given historical date. On July 26, 2024 MyMD was worth 1.82 at the beginning of the trading date compared to the closed value of 1.92. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MyMD Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find MyMD Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MyMD Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MyMD Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
1.82 | 1.97 | 1.82 | 1.86 | 23,582 | |
07/26/2024 | 1.82 | 1.92 | 1.82 | 1.92 | 14,572 |
1.90 | 2.00 | 1.88 | 1.93 | 36,238 |
Backtest MyMD Pharmaceuticals | | | MyMD Pharmaceuticals History | | | MyMD Pharmaceuticals Valuation | Previous | Next |
MyMD Pharmaceuticals Trading Date Momentum on July 26, 2024
On July 29 2024 MyMD Pharmaceuticals was traded for 1.93 at the closing time. The top price for the day was 2.00 and the lowest listed price was 1.88 . The trading volume for the day was 36.2 K. The trading history from July 29, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 0.52% . The trading delta at closing time against the current closing price is 4.17% . |
MyMD Pharmaceuticals Fundamentals Correlations and Trends
By evaluating MyMD Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MyMD Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MyMD financial account trend analysis is a perfect complement when working with valuation or volatility modules.About MyMD Pharmaceuticals Stock history
MyMD Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MyMD is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MyMD Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MyMD Pharmaceuticals stock prices may prove useful in developing a viable investing in MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company was founded in 2014 and is headquartered in Baltimore, Maryland. Mymd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.
MyMD Pharmaceuticals Stock Technical Analysis
MyMD Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
MyMD Pharmaceuticals Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
MyMD Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
MyMD Pharmaceuticals December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how MyMD Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MyMD Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying MyMD Pharmaceuticals stock market strength indicators, traders can identify MyMD Pharmaceuticals entry and exit signals to maximize returns
MyMD Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for MyMD Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of MyMD Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MyMD to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.11) | |||
Jensen Alpha | (0.72) | |||
Total Risk Alpha | (0.95) | |||
Treynor Ratio | 1.16 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in MyMD Stock
If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Transaction History View history of all your transactions and understand their impact on performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stocks Directory Find actively traded stocks across global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Bonds Directory Find actively traded corporate debentures issued by US companies |